Zacks.com on MSN

Here's Why You Should Hold DexCom Stock in Your Portfolio for Now

DexCom, Inc. DXCM is well positioned for growth in the coming quarters, supported by the significant potential of the continuous glucose monitoring (CGM) market. A strong fourth-quarter 2025 ...

Europe Blood Glucose Monitoring Market Report 2026-2031: Revenues to Exceed USD 9 Billion by 2031

Opportunities include integrating digital health for remote care, leveraging demographic trends, and overcoming CGM unit costs to expand access across regionsDublin, March 16, 2026 (GLOBE NEWSWIRE) -- ...

Dexcom gives sneak preview of CGM technologies’ long-term health benefits for diabetics

Dexcom will present the full data from several studies at the Advanced Technologies and Treatments for Diabetes conference, ...

We tried continuous glucose monitors from Lingo and Stelo for 2 weeks. Here’s which one is better

Our editors tested two popular glucose monitors to determine which is the best for improving ​​diet, sleep and exercise habits.
Fierce Biotech

Insulet recalls certain Omnipod 5 pumps over insulin leak risks

Insulet has begun recalling specific lots of its Omnipod 5 insulin pumps in the U.S. | The diabetes tech company said it is ...
MedTech Dive

Insulet reports 18 serious adverse events with recall of Omnipod 5 insulin pumps

The company is recalling certain lots of its insulin patch pumps after finding a small tear in the internal tubing may cause ...

First Ever Real-World Evidence of Eversense 365 Presented at ATTD Demonstrates Sustained Performance and Positive Impact Throughout One-Year of Wear

New data shows positive real-world impact of the world’s first and only one-year CGM, with a full year of strong patient adherence, glucometrics ...
Drug Delivery Business

Senseonics reports sustained year-long CGM implant outcomes, insulin pump integration benefits

Senseonics (Nasdaq:SENS) announced new data from a real-world study demonstrating the sustained performance of its Eversense ...